Udmærkelser
Det er vores forpligtelse at opdage, udvikle og levere innovative lægemidler, der hjælper patienter med at overvinde alvorlige sygdomme. De skridt vi har taget, og den kultur vi har skabt, er yderst værdsat og anerkendt.
Over årene har Bristol-Myers Squibb og virksomhedens medarbejdere modtaget adskillige fremtrædende priser og anerkendelser, herunder Great Place to Work i Danmark, the National Medal of Technology, the Lasker Award for medicinsk forskning og the Prix Galien Award.
År efter år er vi blevet hyldet som en af de bedste virksomheder for arbejdende mødre, et godt sted at være for forskere samt førende i industrien i forhold til miljø og sundhed.
Nedenstående er et udpluk af de priser og anerkendelser, vi har modtaget.
100 Best Corporate Citizens 2017
For the ninth consecutive year, Bristol-Myers Squibb ranks in the top 20 of the 100 Best Corporate Citizens, a leading benchmark for socially responsible investors and other stakeholders published by Corporate Responsibility magazine. “We are proud to be recognized as a leader in Corporate Social Responsibility and sustainability, and will continue to strive to set the bar higher for ourselves, our partners and our suppliers.”
CEO Cancer Gold Standard
The CEO Roundtable on Cancer has accredited Bristol-Myers Squibb with the CEO Cancer Gold Standard™ recognizing our efforts to reduce the risk of cancer for employees and covered family members.
Dow Jones' 2016 North American Index of Leading Sustainable Companies
We are recognized as one of Dow Jones’ 2016 North America Index of Leading Sustainable Companies. Our efforts to promote economic, social and environmental sustainability are core to our company’s mission and reflect our ongoing commitment to patients, our employees and partners, the environment and communities around the world.
America’s Best Employers for 2016
Bristol-Myers Squibb is recognized by Forbes as one of America’s Best Employers for 2016. Our employees are committed to our mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
2015 Society for Immunotherapy of Cancer (SITC) Collaborator Award
We’ve been honored with the 2015 Society for Immunotherapy of Cancer (SITC) Collaborator Award (Industry) for demonstrating ongoing collaboration and continued commitment toward the advancement of cancer immunotherapy. The award was part of SITC’s 30th Anniversary Awards, which were created to highlight groups and individuals who stand out as advocates for the society, and whose involvement in the organization has strengthened its position in the growing field of cancer immunotherapy.
Great Place to Work
For us as an employer our employees experience at work is important so therefore have we choose to be part of the Great Place to Work program.
2016 Working Mother 100 Best Companies
We are one of the 2016 Working Mother 100 Best Companies - marking the 19th consecutive year that our company has made the list. The company was recognized for on-and near-site childcare options and full benefit eligibility.
Most Admired Company in Supplier Diversity
We were recognized as a Most Admired Company in Supplier Diversity by Minority Business News as one of 101 companies that support minority business development through supplier diversity efforts to help ensure continued growth for small businesses.
“Simply the Best” Award
We were honored with the “Simply the Best” Award from the Bonnie J. Addario Lung Cancer Foundation (ALCF) for improving and advancing research for lung cancer. The award was part of ALCF’s Tenth Annual “Simply the Best“ Gala, which recognizes researchers, dedicated physicians and clinicians for their ongoing work fighting lung cancer.
2015 Collaborator Award
Bristol-Myers Squibb received the 2015 Collaborator Award from the Multiple Myeloma Research Foundation (MMRF) in recognition of the company’s commitment to collaboration and to advancing the research and development of novel therapies for patients with multiple myeloma. The Collaborator Award is part of an annual initiative by the MMRF to recognize the exceptional work of its partners from industry and academia who have played a critical role toward pursuing innovative means in the development of next-generation multiple myeloma treatments
Best Places to Work across the U.S. and the U.K.
Glassdoor announced its seventh annual Employees' Choice Awards, honoring the Best Places to Work across the U.S. and the U.K. Winners were determined by the people who know these companies best -- their employees. Bristol-Myers Squibb was among the top 50 companies recognized as a best place to work.
100% score on the 2017 Corporate Equality Index (CEI)
For the 11th consecutive year, we received a perfect score of 100% on the 2017 Corporate Equality Index (CEI), a national review of workplace equality conducted annually by the Human Rights Campaign Foundation, the nation’s largest lesbian, gay, bisexual and transgender (LGBT) civil rights organization.
2016 NAFE Top Companies for Executive Women
We’ve been named one of the 2016 NAFE Top Companies for Executive Women. The company was recognized for leadership initiatives, executive mentoring and sponsorship programs for female employees. Additional education and training through our seven People and Business Resource Groups, five on-site child care centers and a new network for people who choose adoption were also highlighted.
World’s Most Innovative Companies for 2016 / Top 10 Most Innovative Companies in Biotech
Bristol-Myers Squibb is recognized by Fast Company -- the trend-setting business innovations magazine and social platform -- as one of the World’s Most Innovative Companies for 2016 and one of the Top 10 Most Innovative Companies in Biotech.
Top 8 Pharma Companies to Work For
We are featured as one of the Top 8 Pharma Companies to Work For in a survey conducted by Biospace, a leading online community for industry news and careers. “People join Bristol-Myers Squibb because they are passionate about working for patients,” said Ann Judge, Global Head of Human Resources, Bristol-Myers Squibb. “We empower our people to pursue innovation and challenge the status quo. Our diverse global team is reflective of an inclusive culture that appreciates differences and embraces new ideas.”
2015 Top 20 R&D Employer
In October, we were recognized by Science Careers as a 2015 Top 20 R&D Employer. Our company was lauded for being an “Innovating leader in the industry” and commended for the respect afforded our employees and the loyalty they show in return. Science also noted our willingness to take risks that are backed by good science and our leading position in Immuno-Oncology. Overall, Science Careers found that Bristol-Myers Squibb is an exciting place to work.
2017 Energy Star Partner of the Year
Bristol-Myers Squibb is recognized as a 2017 Energy Star Partner of the Year by the U.S. Environmental Protection Agency and U.S. Department of Energy. We are engaged in comprehensive policies and programs to manage energy use at facilities worldwide.
Pharmaceutical Executive Magazine/PharmExec.com’s 2016 Brand of the Year
Bristol-Myers Squibb’s OPDIVO® (nivolumab) was a unanimous selection or Pharmaceutical Executive Magazine/PharmExec.com’s 2016 Brand of the Year. Pharm Exec’s Editorial Advisory Board notes that Opdivo has “raced into the lead position in the treatment-shifting immuno-oncology space behind launches in three key cancers—melanoma, lung, and renal,” in announcing the 10th annual award in its May issue.
World’s Most Admired Companies
Bristol-Myers Squibb ranks number four among the World’s Most Admired Companies in the pharmaceutical industry, according to the 2016 annual ranking published by FORTUNE magazine. Bristol-Myers Squibb ranked in the top three pharmaceutical companies for innovation, people management, quality of products and services, and use of corporate assets.
Top 30 Best-of-the-Best
We were honored as a Top 30 Best-of-the-Best company by the National Gay & Lesbian Chamber of Commerce in collaboration with its partners in the National Business Inclusion Consortium. This year’s inaugural list recognizes U.S. companies committed to diversity and inclusion across all community sectors.
Best Biotechnology Product
Bristol-Myers Squibb’s OPDIVO® (nivolumab) received the Prix Galien USA 2015 Award for Best Biotechnology Product. This represents the second award from Prix Galien USA given to Bristol-Myers Squibb’s Immuno-Oncology portfolio. YERVOY®(ipilimumab) was awarded the prestigious Prix Galien USA prize for Best Biotechnology Product in 2012.
50 Smartest Companies
In June, the MIT Technology Review named Bristol-Myers Squibb to its 50 Smartest Companies list for 2015. We were ranked No. 26 and recognized as a leader in Immuno-Oncology.